Core B: Shared Resource Core For Characterizing Antibody Responses To SARS-CoV-2 And Other Pathogenic Human Coronaviruses
Core B: Shared Resource Core For Characterizing Antibody Responses To SARS-CoV-2 And Other Pathogenic Human Coronaviruses
批准号:
10222242
负责人:
Aravinda M. DeSilva
金额:
$52.88万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-30 至 2022-08-31
关键词:
2019-nCoVAffinityAntibodiesAntibody ResponseAntigen ReceptorsAntigensB-LymphocytesBiological AssayContainmentCoronavirusCoronavirus spike proteinDetectionEnzyme-Linked Immunosorbent AssayExposure toFc ReceptorGoalsGoldHealth care facilityImmuneImmune SeraImmunoglobulin GenesIndividualInfectionLabelLengthMammalian CellMeasuresMethodsMiddle East Respiratory SyndromeN-terminalNorth CarolinaNucleocapsidParalysedPathogenicityPatternProductionPropertyProteinsRecombinantsResearchResearch Project GrantsResource SharingSARS coronavirusScienceSerologic testsSerologicalSerumSevere Acute Respiratory SyndromeSiteSorting - Cell MovementSpecificityStructureSystemTestingVaccinesViralViral PathogenesisVirusbasehuman coronavirusmilligrampandemic diseasereceptor binding
中文摘要
摘要
迫切需要高质量的重组抗原和可靠准确的SARS-CoV-2血清学检测方法
用于监测和确定病毒发病的免疫机制、病毒清除和
防止再次感染。北卡罗来纳大学SARS-CoV-2血清学卓越中心的核心B将
应用最先进的战略,建立生产毫克量均质的方法
重组刺突蛋白冠状病毒抗原,具有通用标签和位点特异性标签,并使用这些抗原
建立灵敏可靠的单链抗体和多链抗体检测方法。核心B将交互并支持所有
由该中心和合作者推动的项目通过提供重组抗原和血清学检测来
鉴定血清抗体反应,阐明Fc效应器的功能谱,并分离和测序
抗原特异性免疫球蛋白基因谱系。
英文摘要
Abstract
High-quality recombinant antigens and reliable and accurate SARS-CoV-2 serological assays are urgently
needed for surveillance and for defining the immune mechanisms of viral pathogenesis, viral clearance, and
protection against reinfection. Core B of the UNC SARS-CoV-2 Serological Sciences Center of Excellence will
apply state-of-the-art strategies to establish methods for the production of milligram quantities of homogeneous
recombinant spike protein CoV antigens with versatile tags and site-specific labels and use these antigens to
develop sensitive and reliable singleplex and multiplex Ab detection assays. Core B will interact and support all
the projects driven by the center and collaborators' by providing recombinant antigens and serological assays to
characterize the serum antibody response, elucidate Fc effector functional profiles, and isolate and sequence
antigen-specific immunoglobulin gene repertoire.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure based design of dengue subunit vaccines for inducing protective but not disease enhancing antibodies
-
批准号:10392040
-
项目类别:
-
资助金额:$72.32万
-
财政年份:2022
-
负责人:Aravinda M. DeSilva
-
依托单位:
Structure based design of dengue subunit vaccines for inducing protective but not disease enhancing antibodies
-
批准号:10612354
-
项目类别:
-
资助金额:$72.32万
-
财政年份:2022
-
负责人:Aravinda M. DeSilva
-
依托单位:
Multiplex serological assays to support arbovirus diagnosis, surveillance and vaccines
-
批准号:10398179
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2020
-
负责人:Aravinda M. DeSilva
-
依托单位:
Multiplex serological assays to support arbovirus diagnosis, surveillance and vaccines
-
批准号:10611391
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2020
-
负责人:Aravinda M. DeSilva
-
依托单位:
Multiplex serological assays to support arbovirus diagnosis, surveillance and vaccines
-
批准号:10162498
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2020
-
负责人:Aravinda M. DeSilva
-
依托单位:
Core B: Shared Resource Core For Characterizing Antibody Responses To SARS-CoV-2 And Other Pathogenic Human Coronaviruses
-
批准号:10688373
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2020
-
负责人:Aravinda M. DeSilva
-
依托单位:
Structure based design of recombinant Zika virus antigens for serodiagnosis
-
批准号:9404101
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2017
-
负责人:Aravinda M. DeSilva
-
依托单位:
Molecular Basis of Dengue Virus Neutralization by Human Antibodies
-
批准号:9206604
-
项目类别:
-
资助金额:$9.82万
-
财政年份:2016
-
负责人:Aravinda M. DeSilva
-
依托单位:
PRECLINICAL ASSAYS TO PREDICT TETRAVALENT DENGUE VACCINE EFFICACY
-
批准号:9901414
-
项目类别:
-
资助金额:$107.57万
-
财政年份:2016
-
负责人:Aravinda M. DeSilva
-
依托单位:
PRECLINICAL ASSAYS TO PREDICT TETRAVALENT DENGUE VACCINE EFFICACY
-
批准号:9153244
-
项目类别:
-
资助金额:$140.1万
-
财政年份:2016
-
负责人:Aravinda M. DeSilva
-
依托单位:
PROJECT 2: Linking Vaccine-Induced Antibody Responses to Protective or Disease Enhancing Immunity
-
批准号:10458129
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2015
-
负责人:Aravinda M. DeSilva
-
依托单位:
PROJECT 2: Linking Vaccine-Induced Antibody Responses to Protective or Disease Enhancing Immunity
-
批准号:10244877
-
项目类别:
-
资助金额:$40.7万
-
财政年份:2015
-
负责人:Aravinda M. DeSilva
-
依托单位:
Molecular Basis of Dengue Virus Neutralization by Human Antibodies
-
批准号:8574001
-
项目类别:
-
资助金额:$47.3万
-
财政年份:2013
-
负责人:Aravinda M. DeSilva
-
依托单位:
Molecular Basis of Flavivirus Cross-Neutralization by Human Antibodies
-
批准号:9790956
-
项目类别:
-
资助金额:$57.32万
-
财政年份:2013
-
负责人:Aravinda M. DeSilva
-
依托单位:
Molecular Basis of Flavivirus Cross-Neutralization by Human Antibodies
-
批准号:10462622
-
项目类别:
-
资助金额:$57.16万
-
财政年份:2013
-
负责人:Aravinda M. DeSilva
-
依托单位:
Molecular Basis of Dengue Virus Neutralization by Human Antibodies
-
批准号:8713933
-
项目类别:
-
资助金额:$48.7万
-
财政年份:2013
-
负责人:Aravinda M. DeSilva
-
依托单位:
Molecular Basis of Dengue Virus Neutralization by Human Antibodies
-
批准号:8891931
-
项目类别:
-
资助金额:$48.7万
-
财政年份:2013
-
负责人:Aravinda M. DeSilva
-
依托单位:
Molecular Basis of Flavivirus Cross-Neutralization by Human Antibodies
-
批准号:10245040
-
项目类别:
-
资助金额:$57.16万
-
财政年份:2013
-
负责人:Aravinda M. DeSilva
-
依托单位:
Molecular Basis of Dengue Virus Neutralization by Human Antibodies
-
批准号:9111844
-
项目类别:
-
资助金额:$86.2万
-
财政年份:2013
-
负责人:Aravinda M. DeSilva
-
依托单位:
Dissecting the Human Antibody Response to Dengue Virus
-
批准号:8528904
-
项目类别:
-
资助金额:$33.45万
-
财政年份:2012
-
负责人:Aravinda M. DeSilva
-
依托单位:
海外基金